The University of California, San Diego School of Medicine has received a $1 million grant from the California Telemedicine & eHealth Center (CTEC) to support the development and implementation of a Southern California Telemedicine Learning Center (TLC).
Researchers from The Ludwig Institute and the University of California, San Diego (UCSD) School of Medicine have discovered that when motor neurons damaged by amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, inappropriately send the wrong signal, immune cells react by killing the messenger. Their surprising finding provides new direction for therapies to treat ALS.
Studies may point to new drug targets for heritable conditions. Daniel O'Connor, M.D., Professor of Medicine and Pharmacology at the University of California, San Diego (UCSD) School of Medicine has studied about 265 twin pairs over the past few years, which has led him to some surprising discoveries.
Building on their 2005 discovery of an enzyme that is a natural tumor suppressor, researchers at the University of California, San Diego (UCSD) School of Medicine have now identified two variants of that enzyme which could provide new targets for therapies to treat diabetes, heart and neurological disease.
Since the advent of the California Tobacco Control Program, in 1989, the state's young adult smokers are quitting the habit in record numbers and older smokers are consuming far fewer cigarettes, according to a new series of studies from the Moores Cancer Center at University of California, San Diego (UCSD).
UCSD Healthcare and the California Poison Control System offer these summertime tips to help keep the season safe.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right